MedPath
FDA Approval

Etesevimab

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Eli Lilly and Company
DUNS: 006421325
Effective Date
January 24, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Etesevimab(35 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Eli Lilly and Company

006421325

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Etesevimab

Product Details

NDC Product Code
0002-7950
Route of Administration
INTRAVENOUS
Effective Date
August 11, 2021
Code: N7Q9NLF11IClass: ACTIBQuantity: 35 mg in 1 mL
HistidineInactive
Code: 4QD397987EClass: IACTQuantity: 1.55 mg in 1 mL
WaterInactive
Code: 059QF0KO0RClass: IACT
Histidine Monohydrochloride MonohydrateInactive
Code: X573657P6PClass: IACTQuantity: 2.10 mg in 1 mL
SucroseInactive
Code: C151H8M554Class: IACTQuantity: 80.4 mg in 1 mL
Polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACTQuantity: 0.50 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath